Who owns Aligos Therapeutics, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of ALGS from SEC Form 13F filings across 36 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 36 institutions disclosed 2.5M shares of Aligos Therapeutics, Inc. worth $14.3M — about 24.2% of shares outstanding; the largest disclosed holder is Deep Track Capital, LP. Source: SEC Form 13F filings, parsed by EvidInvest.
36
13F holders
$14.3M
value, 2026 filers
24.2%
of shares outstanding (2.5M sh)
10
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of ALGS's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Deep Track Capital, LP | 444,110 | $2.5M | 0.0% | 4.2% | 0.0% |
| 2 | Sio Capital Management, LLC | 327,237 | $1.8M | 0.3% | 3.1% | 0.0% |
| 3 | Parkman Healthcare Partners LLCNEW | 325,537 | $1.8M | 0.2% | 3.1% | new |
| 4 | MARSHALL WACE, LLP | 246,579 | $1.4M | 0.0% | 2.4% | 0.0% |
| 5 | Schonfeld Strategic Advisors LLCNEW | 181,880 | $1.0M | 0.0% | 1.7% | new |
| 6 | Woodline Partners LP | 177,362 | $998,548 | 0.0% | 1.7% | 0.0% |
| 7 | VANGUARD CAPITAL MANAGEMENT LLC | 175,543 | $988,307 | 0.0% | 1.7% | 0.0% |
| 8 | BAKER BROS. ADVISORS LP | 83,055 | $467,600 | 0.0% | 0.8% | 0.0% |
| 9 | HHLR ADVISORS, LTD. | 76,247 | $429,271 | 0.0% | 0.7% | 0.0% |
| 10 | D. E. Shaw & Co., Inc. | 71,528 | $402,703 | 0.0% | 0.7% | +7.6% |
| 11 | UBS Group AG | 67,298 | $378,888 | 0.0% | 0.6% | +12.2% |
| 12 | GEODE CAPITAL MANAGEMENT, LLC | 50,310 | $283,375 | 0.0% | 0.5% | +6.6% |
| 13 | PRUDENTIAL FINANCIAL INCNEW | 45,354 | $255,343 | 0.0% | 0.4% | new |
| 14 | LPL Financial LLCNEW | 38,170 | $214,897 | 0.0% | 0.4% | new |
| 15 | BlackRock, Inc. | 29,536 | $166,288 | 0.0% | 0.3% | -2.5% |
| 16 | VANGUARD FIDUCIARY TRUST CO | 28,612 | $161,086 | 0.0% | 0.3% | 0.0% |
| 17 | TWO SIGMA INVESTMENTS, LPNEW | 27,522 | $154,949 | 0.0% | 0.3% | new |
| 18 | DIMENSIONAL FUND ADVISORS LP | 21,044 | $118,478 | 0.0% | 0.2% | 0.0% |
| 19 | GSA CAPITAL PARTNERS LLPNEW | 20,714 | $117,000 | 0.0% | 0.2% | new |
| 20 | Trexquant Investment LP | 19,395 | $109,194 | 0.0% | 0.2% | +57.2% |
| 21 | Verition Fund Management LLC | 18,887 | $106,334 | 0.0% | 0.2% | 0.0% |
| 22 | RENAISSANCE TECHNOLOGIES LLC | 15,100 | $85,013 | 0.0% | 0.1% | +39.8% |
| 23 | Quadrature Capital LtdNEW | 13,406 | $75,476 | 0.0% | 0.1% | new |
| 24 | CITADEL ADVISORS LLCNEW | 11,539 | $64,965 | 0.0% | 0.1% | new |
| 25 | Rockefeller Capital Management L.P. | 10,276 | $57,854 | 0.0% | 0.1% | +2.8% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.